title: Cyclooxygenase-2 inhibitor update.
authors.forename: Ken
authors.initials: K
authors.lastname: Bassett
authors.forename: Jim M
authors.initials: JM
authors.lastname: Wright
authors.forename: Lorri
authors.initials: L
authors.lastname: Puil
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Perry
authors.forename: Balraj
authors.initials: B
authors.lastname: Heran
authors.forename: Balraj
authors.initials: B
authors.lastname: Cole
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003257:Consumer Product Safety; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D033181:Information Dissemination; D007527:Isoenzymes; D008565:Membrane Proteins; D010437:Peptic Ulcer / Q000139:chemically induced; D011451:Prostaglandin-Endoperoxide Synthases; D013927:Thrombosis / Q000139:chemically induced
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases